Replies to post #125971 on OWC Pharmaceutical Research Corp (OWCP)

[Farmer7]

Gary, although I don't talk about it, I'm fully aware and excited for this fibromyalgia/pain study, phase 2. The company is a sleeping giant, and again is very undervalued compared to its peers.

[JJ8]

Psoriasis treatment is a multi-billion dollar market

According to the International Federation of Psoriasis Association, circa 5% people suffer from one or more forms of psoriasis, globally.

In the U.S. alone, the condition affects nearly 7.5 million people, which is roughly 2% of the population.

The global market for psoriasis treatment, which was valued at US$7.8 billion in 2015, is projected to expand at a compound annual growth rate (CAGR) of 5.1% to reach US$12.1 billion by 2024.

[nlightn]

it really depends what perspective is being used to gauge the "mystery".

you stated,..

So much the company is doing is a mystery.


in the perspective of OWCP's product line and OWCP's management's ability capture the global market,...then yes, shareholders don't yet have that complete information. it's a guessing game at best. but,...

if the shareholder looks at the recent events of placing particular high-calibar Directors and BOD,...then the perspective becomes clear.

why would a prestigious company such as Jones Day accept a position utilizing one of their premier attorneys as Director with this little now unknown .45 company ?

the simple and obvious answer which is revealing itself is,...

OWCP has the goods.

time to collect more shares 8^)